e-learning
resources
Glasgow 2004
Saturday 04.09.2004
PG20 - State-of-the art in management of pleural diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contemporary management of malignant mesothelioma
P. Baas (Amsterdam, The Netherlands)
Source:
Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases
Session:
PG20 - State-of-the art in management of pleural diseases
Session type:
Postgraduate Course
Number:
67
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Baas (Amsterdam, The Netherlands). Contemporary management of malignant mesothelioma. Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Management of malignant mesothelioma
Source: ERS Skills Course 2018 - Practical Pleural Skills
Year: 2018
Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Guideline 2020
Year: 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019
Year: 2020
Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015
Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012
Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Multimodality therapy for malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004
Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004
Treatment of malignant pleural mesothelioma: dilemmas
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016
Update on biology and management of mesothelioma
Source: Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020
Year: 2021
Malignant pleural mesothelioma: our multimodality approach
Source: Eur Respir J 2002; 20: Suppl. 38, 40s
Year: 2002
Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept